CatalystPit

VCYTVERACYTE, INC.

NASDAQ · SERVICES-MEDICAL LABORATORIES
Last close $46.04 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustrySERVICES-MEDICAL LABORATORIES
Market cap$3.70B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-22 · Leite John (Global Chief Commercial Off) · SELL
  • 2026-09-16 · Holstein Jens (Director) · SELL
  • 2026-09-04 · Febbo Phillip G. (Chief Scientific & Med Officer) · SELL
  • 2026-09-04 · McGuire Annie (EVP, General Counsel) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders396
Shares held108,272,835
Value$5.75B
Percent of shares outstanding134.68%
As of quarter end2026-06-30
RECENT NEWS
  • Cathie Wood’s ARK sells Teradyne stock, buys Veracyte
  • Veracyte's Decipher test predicts hormone therapy benefit in prostate cancer
  • Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
  • Veracyte global chief commercial off. John Leite sells $160,600 stock
  • Veracyte presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS